Scott Rairigh
About Scott Rairigh
Scott Rairigh is the Executive Director of Precision Medicine and Diagnostics at Bristol Myers Squibb in Summit, NJ, with extensive experience in companion diagnostics and personalized medicine.
Current Role at Bristol Myers Squibb
Scott Rairigh currently holds the role of Executive Director, Precision Medicine and Diagnostics at Bristol Myers Squibb in Summit, NJ. In this capacity, he leads the strategic efforts and commercialization strategy for precision medicine and diagnostics within the pharmaceutical global marketing division. His focus encompasses companion diagnostic business approaches, ensuring that innovation and precision are at the forefront of the company's diagnostic solutions.
Previous Experience at Janssen
From 2010 to 2017, Scott Rairigh served as the Global Marketing Leader, Companion Diagnostics at Janssen, Pharmaceutical Companies of Johnson & Johnson. Over his seven-year tenure, he spearheaded global marketing initiatives and fostered robust strategies for companion diagnostics. This role allowed him to harness his extensive expertise in personalized medicine and drive substantial advancements in the field.
Leadership at Virco Lab Inc.
Scott Rairigh was Vice President, US Business at Virco Lab Inc., a Johnson & Johnson Company, from 2004 to 2010. He significantly contributed to positioning Virco as a leader in the quantitative HIV resistance testing market. Under his leadership, the company successfully expanded its product portfolio by acquiring LabTracker from Ground Zero Software and executed a notable co-marketing agreement with Tibotec Therapeutics.
Educational Background
Scott Rairigh's educational journey includes a Master of Science (M.S.) in Finance from The Johns Hopkins University - Carey Business School and a Bachelor of Science (B.S.) in Biology with a Chemistry minor from Towson University. Additionally, he completed the Strategic Leadership Program at Harvard Business School, further honing his leadership and strategic planning skills.
Expertise in Pharmaceutical Marketing and Diagnostics
Scott Rairigh's extensive career spans multiple roles emphasizing strategic planning and execution, product portfolio management, and global medical markets. His expertise covers companion diagnostics, personalized medicine, health information technology, process excellence, and groundbreaking innovation. Throughout his career, he has led various successful initiatives, including achieving over $100 million in sales and 90% market share in Molecular Diagnostics at Roche Diagnostics and significantly increasing the Immunodiagnostics franchise sales at Ortho Clinical Diagnostics.